Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer E Weiss

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Rheumatology (Oxford, England)|January 28, 2021
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritisNicolino Ruperto, Hermine I Brunner, Athimalaipet V Ramanan, et al.
Frontiers in Pediatrics|August 19, 2024
Using a collaborative learning health system approach to improve disease activity outcomes in children with juvenile idiopathic arthritis in the Pediatric Rheumatology Care and Outcomes Improvement NetworkJulia G Harris, Catherine A Bingham, Sheetal S Vora, et al.
Pediatric Rheumatology Online Journal|July 25, 2023
"I'd like more options!": Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritisKarine Toupin-April, Isabelle Gaboury, Laurie Proulx, et al.
Annals of the Rheumatic Diseases|June 7, 2024
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension studyHermine I Brunner, Jonathan D Akikusa, Eslam Al-Abadi, et al.
Pediatric Rheumatology Online Journal|February 8, 2022
Translating research into practice-implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retreatCagri Yildirim-Toruner, Rajdeep Pooni, Y Ingrid Goh, et al.
Arthritis Care & Research|October 22, 2014
Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance projectSarah Ringold, Audrey Hendrickson, Leslie Abramson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2014
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisSergio Davì, Francesca Minoia, Angela Pistorio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort StudyDavid A Cabral, Debra L Canter, Eyal Muscal, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of TherapyClaas H Hinze, Dirk Foell, Anne L Johnson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2018
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive DiseaseDaniel J Lovell, Anne L Johnson, Bin Huang, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Rheumatology (Oxford, England)|January 28, 2021
Subcutaneous dosing regimens of tocilizumab in children with systemic or polyarticular juvenile idiopathic arthritisNicolino Ruperto, Hermine I Brunner, Athimalaipet V Ramanan, et al.
Frontiers in Pediatrics|August 19, 2024
Using a collaborative learning health system approach to improve disease activity outcomes in children with juvenile idiopathic arthritis in the Pediatric Rheumatology Care and Outcomes Improvement NetworkJulia G Harris, Catherine A Bingham, Sheetal S Vora, et al.
Pediatric Rheumatology Online Journal|July 25, 2023
"I'd like more options!": Interviews to explore young people and family decision-making needs for pain management in juvenile idiopathic arthritisKarine Toupin-April, Isabelle Gaboury, Laurie Proulx, et al.
Annals of the Rheumatic Diseases|June 7, 2024
Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension studyHermine I Brunner, Jonathan D Akikusa, Eslam Al-Abadi, et al.
Pediatric Rheumatology Online Journal|February 8, 2022
Translating research into practice-implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retreatCagri Yildirim-Toruner, Rajdeep Pooni, Y Ingrid Goh, et al.
Arthritis Care & Research|October 22, 2014
Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance projectSarah Ringold, Audrey Hendrickson, Leslie Abramson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 22, 2014
Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritisSergio Davì, Francesca Minoia, Angela Pistorio, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 26, 2016
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort StudyDavid A Cabral, Debra L Canter, Eyal Muscal, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2018
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of TherapyClaas H Hinze, Dirk Foell, Anne L Johnson, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 1, 2018
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive DiseaseDaniel J Lovell, Anne L Johnson, Bin Huang, et al.
Pageof 4